首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1490006

荷爾蒙補充療法市場：依治療類型、給藥途徑、應用、分銷管道和地區

Hormone Replacement Therapy Market, By Therapy Type, By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月10日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

估計2024年全球荷爾蒙補充療法市場規模為148.9億美元，預計2031年將達220.4億美元，2024年至2031年年複合成長率為5.8%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	148.9億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測2024-2031年年複合成長率：	5.80%	2031年價值預測	220.4億美元

圖：2024年荷爾蒙補充療法市場佔有率（%），依地區分類

由於世界各地女性更年期症狀的盛行率不斷上升，全球荷爾蒙補充療法市場在過去幾年中出現了顯著成長。荷爾蒙補充療法可以幫助治療更年期後出現的各種症狀，包括潮熱、盜汗、陰道乾燥、性慾下降和情緒低落。人們對骨質疏鬆症和其他由荷爾蒙失衡和老齡化引起的慢性疾病的健康擔憂日益增加，推動了對有效治療解決方案的需求。此外，對女性健康問題的認知不斷提高以及各種荷爾蒙替代製劑的供應預計將在預測期內推動市場擴張。然而，與長期使用荷爾蒙藥物相關的副作用和替代治療方案的可用性等因素繼續在一定程度上抑制市場成長。

市場動態：

推動全球荷爾蒙補充療法市場的關鍵因素包括易患荷爾蒙缺乏的老年人口迅速增加、女性更年期發病率上升、全球文明病迅速增加以及慢性病管理中荷爾蒙補充療法的增加。同時，長期使用荷爾蒙藥物的副作用，包括乳癌、心臟病、中風和血栓，給市場相關人員帶來了重大挑戰。然而，新型藥物輸送系統、各種荷爾蒙組合以及生物同質荷爾蒙配方創新的研發進展預計將在未來幾年為相關人員提供有利的成長機會。

本研究的主要特點

本報告對全球荷爾蒙補充療法市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點，實績和策略等參數，介紹了全球荷爾蒙補充療法市場的主要企業。
主要企業包括Novartis AG、Abbott、Mylan NV、Merck KgaA、Bayer AG、Pfizer Inc.、Novo Nordisk A/S、QuatRx Pharmaceuticals、Teva Pharmaceutical Industries Ltd.、Amgen, Inc.、Eli Lilly and Company、Halozyme Therapeutics, Inc.、AbbVie, Inc.、Noven Pharmaceuticals, Inc.、i-MAB Biopharma Co.
本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球荷爾蒙補充療法市場迎合該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球荷爾蒙補充療法市場的各種策略矩陣來促進他們的決策。

公司簡介
- Novartis AG
- Abbott
- Mylan NV
- Merck KgaA
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- QuatRx Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Amgen, Inc.
- Eli Lilly and Company
- Halozyme Therapeutics, Inc.
- AbbVie, Inc.
- Noven Pharmaceuticals, Inc.
- I-MAB Biopharma Co., Ltd.
- Myovant Sciences

第11章分析師觀點

Wheel of Fortune
分析師觀點
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI2079

The global hormone replacement therapy market is estimated to be valued at USD 14.89 Bn in 2024 and is expected to reach USD 22.04 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 14.89 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	5.80%	2031 Value Projection:	US$ 22.04 Bn

Figure. Hormone Replacement Therapy Market Share (%), By Region, 2024

Hormone Replacement Therapy Market - IMG1

The global hormone replacement therapy market has been witnessing significant growth over the past few years owing to the rising prevalence of menopause among women worldwide. Hormone replacement therapy helps treat various symptoms experienced during and after menopause like hot flashes, night sweats, vaginal dryness, low libido, and mood swings. Growing health concerns pertaining to osteoporosis and other chronic diseases due to hormonal imbalance and aging are driving the demand for effective therapeutic solutions. Furthermore, increasing awareness about women's health issues and availability of various hormone replacement drug formulations are expected to propel the market expansion during the forecast period. However, factors like side effects associated with long-term usage of hormones and availability of alternative treatment options continue to impede the market growth to a certain extent.

Market Dynamics:

The key drivers fueling the global hormone replacement therapy market include rapidly growing geriatric population susceptible to hormonal deficiencies, rising incidence of menopause among women, upsurge in lifestyle diseases globally, and increasing awareness about benefits of hormone replacement therapy in chronic disease management. On the other hand, side effects pertaining to long-term usage of hormones including Breast cancer, heart disease, stroke, and blood clots pose major challenges for market players. However, ongoing R&D towards development of novel drug delivery systems, combining various hormones, and innovation in bioidentical hormone formulations are expected to unlock lucrative growth opportunities for stakeholders in coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hormone replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Novartis AG, Abbott , Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Eli Lilly and Company, Halozyme Therapeutics, Inc., AbbVie, Inc., Noven Pharmaceuticals, Inc., I-MAB Biopharma Co., Ltd., and Myovant Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global hormone replacement therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Detailed Segmentation-

By Therapy Type:
- Estrogen Replacement Therapy
- Human Growth Hormone (HGH) Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
- Others
By Route of Administration:
- Oral
- Parenteral
- Others
By Application:
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Abbott
- Mylan NV
- Merck KgaA
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- QuatRx Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Amgen, Inc.
- Eli Lilly and Company
- Halozyme Therapeutics, Inc.
- AbbVie, Inc.
- Noven Pharmaceuticals, Inc.
- I-MAB Biopharma Co., Ltd.
- Myovant Sciences

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Adoption of Non-invasive Sensor Technologies
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Hormone Replacement Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Hormone Replacement Therapy Market, By Therapy Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Estrogen Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Human Growth Hormone (HGH) Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Thyroid Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Testosterone Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Hormone Replacement Therapy Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Hormone Replacement Therapy Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hypothyroidism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Male Hypogonadism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Growth Hormone Deficiency
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Hormone Replacement Therapy Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Hormone Replacement Therapy Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Novartis AG*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott
- Mylan NV
- Merck KgaA
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- QuatRx Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Amgen, Inc.
- Eli Lilly and Company
- Halozyme Therapeutics, Inc.
- AbbVie, Inc.
- Noven Pharmaceuticals, Inc.
- I-MAB Biopharma Co., Ltd.
- Myovant Sciences